Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related JNJ
Baird Says Buy Cooper Companies At Current Levels
Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet Regimen Odefsey
Hundred Thousand Dollars Of Income Portfolio - June Update (Seeking Alpha)
Related ILMN
What's The Single Best $10,000 Investment To Hold For The Next 25 Years?
Short Interest Surges In Illumina And Vertex Pharmaceuticals

Analysts at Deutsche Bank upgraded Johnson & Johnson (NYSE: JNJ) from “hold” to “buy.” Johnson & Johnson's stock closed at $70.74 yesterday. Johnson & Johnson had $19.77 billion in total cash for the latest quarter.

Piper Jaffray upgraded Illumina (NASDAQ: ILMN) from “neutral” to “overweight.” Illumina's shares closed at $55.55 yesterday. Illumina's PEG ratio is 2.02.

Analysts at Janney Capital upgraded Target (NYSE: TGT) from “neutral” to “buy.” Target's shares closed at $60.16 yesterday. Target's trailing-twelve-month revenue is $71.86 billion.

Needham upgraded Mattel (NASDAQ: MAT) from “hold” to “buy.” Mattel's shares closed at $36.72 yesterday. Mattel's trailing-twelve-month operating margin is 18.67%.

Latest Ratings for JNJ

DateFirmActionFromTo
Jun 2016JefferiesMaintainsHold
May 2016Standpoint ResearchInitiates Coverage onSell
May 2016BTIG ResearchDowngradesBuyNeutral

View More Analyst Ratings for JNJ
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ILMN + JNJ)

View Comments and Join the Discussion!